Prevention investigators in our Center and elsewhere have demonstrated that drug abuse prevention efficacy can be significantly enhanced by targeting individuals who are most vulnerable to developing problems and tailoring message content and format based on the characteristics of these individuals. Our previous work focused on drug use initiation and identified behavioral mechanisms (neurobehavioral response to reinforcing, novel and emotional stimuli) whereby the sensation seeking dimension of impulsivity is associated with vulnerability to drug use initiation and high sensation-value contexts enhance the efficacy of prevention interventions designed to reduce drug use initiation. Further development of laboratory models to identify individuals who are vulnerable to drug use escalation and development of associated problems and identifying the characteristics of these individuals that predispose them to vulnerability and/or influence the efficacy of targeted intervention materials is of critical importance for informing and advancing the field of drug abuse prevention. This application proposes five years of research to continue laboratory investigations of individual differences associated with drug use escalation and associated exposure to heavy drug use. Growing evidence suggests that vulnerability to drug-use escalation is associated with self-control mechanisms. A multidisciplimary approach combining personality measurement with laboratory abuse liability assessment, behavioral inhibition task performance and brain imaging methodologies will be used to examine impulsivity among matched groups of tobacco and marijuana users who have either maintained stable patterns of intermittent/light use (escalation resistant) or who have escalated to heavy use with and without extended histories of heavy use (escalation;escalation + extended drug exposure) to test the hypothesis that drug use escalation is associated with inhibitory neurobehavioral dimensions of impulsivity. Knowledge of the association between component dimensions of impulsivity and drug-use escalation will enhance understanding of vulnerability to and consequences of drug use escalation and thus our ability to design more efficacious tailored and targeted drug abuse prevention interventions.

Public Health Relevance

Drug abuse prevention efficacy is improved by targeting at-risk individuals and tailoring interventions based on the characteristics of those individuals. Impulsivity is closely linked with drug abuse vulnerability. This project will support prevention science by identifying the neurobehavioral dimensions of impulsivity that are associated with vulnerability to and adverse consequences of tobacco and marijuana use escalation.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Specialized Center (P50)
Project #
5P50DA005312-23
Application #
8507675
Study Section
Special Emphasis Panel (ZDA1-EXL-T)
Project Start
Project End
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
23
Fiscal Year
2013
Total Cost
$360,896
Indirect Cost
$116,853
Name
University of Kentucky
Department
Type
DUNS #
939017877
City
Lexington
State
KY
Country
United States
Zip Code
40506
Kaiser, Alison J; Davis, Heather A; Milich, Richard et al. (2018) Bidirectional Relations of Impulsive Personality and Alcohol Use Across Three Waves of Data Collection. Subst Use Misuse 53:2386-2393
Derefinko, Karen J; Bursac, Zoran; Mejia, Michael G et al. (2018) Rural and urban substance use differences: Effects of the transition to college. Am J Drug Alcohol Abuse 44:224-234
Riley, Elizabeth N; Davis, Heather A; Milich, Richard et al. (2018) Heavy, Problematic College Drinking Predicts Increases in Impulsivity. J Stud Alcohol Drugs 79:790-798
Roberts, Bethan; Eisenlohr-Moul, Tory; Martel, Michelle M (2018) Reproductive steroids and ADHD symptoms across the menstrual cycle. Psychoneuroendocrinology 88:105-114
Maggio, Sarah E; Saunders, Meredith A; Nixon, Kimberly et al. (2018) An improved model of ethanol and nicotine co-use in female P rats: Effects of naltrexone, varenicline, and the selective nicotinic ?6?2* antagonist r-bPiDI. Drug Alcohol Depend 193:154-161
Maggio, Sarah E; Saunders, Meredith A; Baxter, Thomas A et al. (2018) Effects of the nicotinic agonist varenicline, nicotinic antagonist r-bPiDI, and DAT inhibitor (R)-modafinil on co-use of ethanol and nicotine in female P rats. Psychopharmacology (Berl) 235:1439-1453
Peters, Jessica R; Eisenlohr-Moul, Tory A; Walsh, Erin C et al. (2018) Exploring the pathophysiology of emotion-based impulsivity: The roles of the sympathetic nervous system and hostile reactivity. Psychiatry Res 267:368-375
Weiss, Virginia G; Yates, Justin R; Beckmann, Joshua S et al. (2018) Social reinstatement: a rat model of peer-induced relapse. Psychopharmacology (Berl) 235:3391-3400
Chester, David S; Lynam, Donald R; Milich, Richard et al. (2018) Neural mechanisms of the rejection-aggression link. Soc Cogn Affect Neurosci 13:501-512
Zapolski, Tamika C B; Rowe, Alia T; Fisher, Sycarah et al. (2018) Peer victimization and substance use: Understanding the indirect effect of depressive symptomatology across gender. Addict Behav 84:160-166

Showing the most recent 10 out of 169 publications